MX2018009331A - Metodos para extraer proteinas a partir de un material a base de sangre. - Google Patents

Metodos para extraer proteinas a partir de un material a base de sangre.

Info

Publication number
MX2018009331A
MX2018009331A MX2018009331A MX2018009331A MX2018009331A MX 2018009331 A MX2018009331 A MX 2018009331A MX 2018009331 A MX2018009331 A MX 2018009331A MX 2018009331 A MX2018009331 A MX 2018009331A MX 2018009331 A MX2018009331 A MX 2018009331A
Authority
MX
Mexico
Prior art keywords
methods
blood
chromatography
proteins
albumin
Prior art date
Application number
MX2018009331A
Other languages
English (en)
Inventor
ZURLO Eugene
Peter Nowotnik David
Heldebrant Charles
Curtin Dennis
Original Assignee
Plasma Tech Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Plasma Tech Llc filed Critical Plasma Tech Llc
Publication of MX2018009331A publication Critical patent/MX2018009331A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • C07K1/303—Extraction; Separation; Purification by precipitation by salting out
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804—Affinity chromatography
    • B01D15/3814—Affinity chromatography of the substrate or co-factor - enzyme type
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/02—Reverse osmosis; Hyperfiltration ; Nanofiltration
    • B01D61/027—Nanofiltration
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14—Ultrafiltration; Microfiltration
    • B01D61/145—Ultrafiltration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2315/00—Details relating to the membrane module operation
    • B01D2315/16—Diafiltration

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Water Supply & Treatment (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se describen en la presente métodos para producir productos de proteína múltiples a partir de materiales a base de sangre, que incluyen inhibidor de alfa-1-proteinasa, gamma-globulina, albúmina, y otros proteínas. Los métodos de la invención incluyen etapas de: fraccionamiento con sal, cromatografía, ultrafiltración, diafiltración, tratamiento con solvente-detergente, y filtración estéril. Ventajosamente, los métodos de la invenicón son simples y producen inhibidor de alfa1-proteinasa, gamma-globulina, albúmina y otras proteínas en altos rendimientos. La secuencia de etapas de proceso puede ser seleccionada para obtener productos múltiples a partir de varios materiales en proceso, como sobrenadantes, pastas, flujo de paso de cromatografía y lavados de cromatografía.
MX2018009331A 2016-02-03 2017-02-03 Metodos para extraer proteinas a partir de un material a base de sangre. MX2018009331A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662290638P 2016-02-03 2016-02-03
PCT/US2017/016595 WO2017136785A1 (en) 2016-02-03 2017-02-03 Methods for extracting proteins from a blood-based material

Publications (1)

Publication Number Publication Date
MX2018009331A true MX2018009331A (es) 2018-11-09

Family

ID=59501069

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018009331A MX2018009331A (es) 2016-02-03 2017-02-03 Metodos para extraer proteinas a partir de un material a base de sangre.

Country Status (9)

Country Link
US (2) US11028125B2 (es)
EP (1) EP3411383A4 (es)
JP (2) JP6946313B2 (es)
KR (1) KR20180101583A (es)
CN (1) CN108779144B (es)
AU (1) AU2017214678B2 (es)
CA (1) CA3012694A1 (es)
MX (1) MX2018009331A (es)
WO (1) WO2017136785A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108473530B (zh) * 2015-10-15 2022-12-23 普莱泽玛科技有限公司 从血浆中提取蛋白质的方法
AU2017214678B2 (en) 2016-02-03 2024-02-01 Plasma Technologies, Llc Methods for extracting proteins from a blood-based material
CN109678969B (zh) * 2018-12-29 2020-02-07 北京东方百泰生物科技有限公司 一种CTLA4-Ig融合蛋白的纯化方法
US10815270B1 (en) * 2019-09-20 2020-10-27 Plasma Technologies, Llc Compositions and methods for high efficiency protein precipitation
WO2021054999A1 (en) * 2019-09-20 2021-03-25 Plasma Technologies, Llc Therapeutic protein compositions and methods
CN112830953A (zh) * 2019-11-22 2021-05-25 中国科学院大连化学物理研究所 一种干细胞培养液中提取活性蛋白的方法
US11732004B2 (en) * 2020-04-10 2023-08-22 Plasma Technologies, Llc Compositions and methods for simplified high efficiency isolation of proteins
CN112409476B (zh) * 2020-08-13 2022-03-29 中元汇吉生物技术股份有限公司 四种血液来源蛋白的纯化方法
WO2023052627A1 (en) 2021-10-01 2023-04-06 Csl Behring Ag Improved purification process
CN114395031A (zh) * 2022-01-24 2022-04-26 华南师范大学 罗非鱼血清转铁蛋白的纯化方法及其应用
CN114835801B (zh) * 2022-06-20 2023-09-22 华润博雅生物制药集团股份有限公司 一种c1酯酶抑制剂及其制备方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2390074A (en) 1942-02-09 1945-12-04 Research Corp Protein product and process
US4404132A (en) 1980-05-27 1983-09-13 Cutter Laboratories, Inc. Blood coagulation promoting product
JPS584728A (ja) * 1981-05-01 1983-01-11 メデイカル・リサ−チ・インステイチユ−ト・オブ・サンフランシスコ・コ−ポレ−シヨン α−１−抗トリプシンの精製
US4639513A (en) * 1984-02-02 1987-01-27 Cuno Inc. Intravenously injectable immunoglobulin G (IGG) and method for producing same
US4486282A (en) 1983-02-22 1984-12-04 University Patents, Inc. Precipitation of proteins from salt-containing proteinaceous fluids employing a desalting treatment, and use thereof in selective plasmapheresis
US4697003A (en) 1985-11-01 1987-09-29 Miles Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor
US5177194A (en) 1990-02-01 1993-01-05 Baxter International, Inc. Process for purifying immune serum globulins
GB9705810D0 (en) 1997-03-20 1997-05-07 Common Services Agency Intravenous immune globulin
US6955917B2 (en) * 1997-06-20 2005-10-18 Bayer Healthcare Llc Chromatographic method for high yield purification and viral inactivation of antibodies
AUPP971399A0 (en) 1999-04-12 1999-05-06 Life Therapeutics Limited Separation of plasma components
SE0001128D0 (sv) * 2000-03-30 2000-03-30 Amersham Pharm Biotech Ab A method of producing IgG
US6881731B1 (en) 2000-10-23 2005-04-19 Shanbrom Technologies, Llc Enhancers for microbiological disinfection
US7297716B2 (en) 2000-10-23 2007-11-20 Shanbrom Technologies, Llc Enhanced production of blood components, blood cells and plasma without freezing
ES2184594B1 (es) 2001-01-17 2004-01-01 Probitas Pharma Sa Procedimiento para la produccion de gammaglobulina g humana inactivada de virus.
MXPA03007069A (es) 2001-02-07 2004-10-15 Shanbrom Tech Llc Acido carboxilico tal como acido citrico para desinfectar o mejorar la produccion de productos sanguineos tales como el plasma, crioprecipitado y/o plaqueta.
DK1654284T3 (da) * 2003-08-12 2009-07-20 Octapharma Ag Fremgangsmåde til fremstilling af en alfa-1-antitrypsinoplösning
US8293242B2 (en) * 2005-09-01 2012-10-23 Plasma Technologies, Llc Ultra-high yield of alpha-1-anti-trypsin
US7879332B2 (en) * 2005-09-01 2011-02-01 Plasma Technologies, Llc Ultra-high yield intravenous immune globulin preparation
US20070049732A1 (en) 2005-09-01 2007-03-01 Zurlo Eugene J Ultra-high yield intravenous immune globulin preparation
GB0524432D0 (en) 2005-11-30 2006-01-11 Nhs Blood & Transplant Method
CN102099369A (zh) 2008-07-18 2011-06-15 泰勒克里斯生物治疗学公司 制备α-1蛋白酶抑制剂的方法
EP2419436A1 (en) * 2009-04-13 2012-02-22 Bristol-Myers Squibb Company Protein purification by citrate precipitation
EP2755992B1 (en) * 2011-09-16 2018-11-14 GE Healthcare BioProcess R&D AB Plasma protein fractionation by sequential polyacid precipitation
CN102599332B (zh) * 2012-03-09 2014-07-30 上海杰隆生物制品股份有限公司 一种利用禽血生产低灰分禽血浆蛋白粉的方法
CN108473530B (zh) * 2015-10-15 2022-12-23 普莱泽玛科技有限公司 从血浆中提取蛋白质的方法
AU2017214678B2 (en) 2016-02-03 2024-02-01 Plasma Technologies, Llc Methods for extracting proteins from a blood-based material

Also Published As

Publication number Publication date
AU2017214678A2 (en) 2018-09-06
CN108779144B (zh) 2022-06-14
EP3411383A1 (en) 2018-12-12
KR20180101583A (ko) 2018-09-12
US11028125B2 (en) 2021-06-08
JP2019513119A (ja) 2019-05-23
JP6946313B2 (ja) 2021-10-06
EP3411383A4 (en) 2019-08-14
CN108779144A (zh) 2018-11-09
US20210261608A1 (en) 2021-08-26
WO2017136785A1 (en) 2017-08-10
AU2017214678A1 (en) 2018-08-16
JP2022000442A (ja) 2022-01-04
CA3012694A1 (en) 2017-08-10
US20190055282A1 (en) 2019-02-21
AU2017214678B2 (en) 2024-02-01

Similar Documents

Publication Publication Date Title
MX2018009331A (es) Metodos para extraer proteinas a partir de un material a base de sangre.
MX2016011641A (es) Procedimiento de preparacion de proteinas plasmaticas humanas.
MX2021005254A (es) Produccion recombinante de una preparacion de peptido de colageno y uso de la misma.
MX2017006866A (es) Pares de unión para producción de péptidos.
EA201890039A1 (ru) Антитела, специфичные к гиперфосфорилированному тау-белку, и способы их применения
WO2016023019A3 (en) Anti-trem2 antibodies and methods of use thereof
MX2018012749A (es) Etanercept plegado correctamente con alta pureza y un rendimiento excelente.
MX2019010392A (es) Moleculas de fusion de ectodominios receptores de tgf-b y sus usos.
MX2020000288A (es) Cromatografia.
ATE541858T1 (de) Präparation von intravenösem immunglobulin mit ultrahoher ausbeute
IL254242A0 (en) Dual signaling fusion proteins and methods of using them to treat diseases
MY189854A (en) Method for protein purification
MX2022011973A (es) Composiciones de proteina anti-vegf y metodos para producir la misma.
EP3491006A4 (en) PROCESS FOR THE PREPARATION OF PROTEINS OR PEPTIDES
MX2019007316A (es) Eliminacion de acidos nucleicos y fragmentos de los mismos de un material de biomasa.
PH12016500403A1 (en) An anti serum albumin fab-effector moiety fusion construct, and the preparing method thereof
PH12020500054A1 (en) Novel therapeutic enzyme fusion protein and use thereof
MX2021001129A (es) Metodo de purificacion de antigenos.
PH12020551955A1 (en) Anti-cd63 antibodies, conjugates, and uses thereof
IL266338A (en) Method for producing a processed soy protein product
MX2015016670A (es) Proceso para preparar apolipoproteina a-i (apo- a-i).
MX2021007444A (es) Proteina biespecifica.
WO2016055064A3 (en) Isolation of soluble proteins from aggregated casein-containing mixtures
PH12019502185A1 (en) Hydrolysed vegetable proteins suitable for use in baby food
EA201791423A1 (ru) Способ получения белка